CCL2 and neoplasm: CCL2 levels quantitatively measured in the plasma of patients were significantly higher than those in age- and gender-matched healthy donors (HD); in patients, higher levels were detected in subjects with a high tumor burden than in those with a low tumor burden (Figure 4AB).